MX2017012359A - Cepas bacterianas productoras de histamina y su uso en cancer. - Google Patents

Cepas bacterianas productoras de histamina y su uso en cancer.

Info

Publication number
MX2017012359A
MX2017012359A MX2017012359A MX2017012359A MX2017012359A MX 2017012359 A MX2017012359 A MX 2017012359A MX 2017012359 A MX2017012359 A MX 2017012359A MX 2017012359 A MX2017012359 A MX 2017012359A MX 2017012359 A MX2017012359 A MX 2017012359A
Authority
MX
Mexico
Prior art keywords
cancer
histamine
bacterial strains
producing bacterial
treatment
Prior art date
Application number
MX2017012359A
Other languages
English (en)
Inventor
Versalovic James
Mí–Llstam Bo
Gao Chunxu
Ganesh Bhanu
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of MX2017012359A publication Critical patent/MX2017012359A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01107—Diacylglycerol kinase (2.7.1.107)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención en la presente describe cepas bacterianas productoras de histamina para usarse en la profilaxis, inhibición, tratamiento o reducción de un riesgo de recaí­da de cáncer, incluyendo cáncer colorrectal. La presente invención también describe el uso de cepas bacterianas productoras de histamina para fabricar un medicamento para tratamiento de cáncer, incluyendo cáncer colorrectal masculino.
MX2017012359A 2015-03-26 2016-03-24 Cepas bacterianas productoras de histamina y su uso en cancer. MX2017012359A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562138491P 2015-03-26 2015-03-26
PCT/SE2016/050253 WO2016153422A1 (en) 2015-03-26 2016-03-24 Histamine-producing bacterial strains and their use in cancer

Publications (1)

Publication Number Publication Date
MX2017012359A true MX2017012359A (es) 2018-07-06

Family

ID=55755642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012359A MX2017012359A (es) 2015-03-26 2016-03-24 Cepas bacterianas productoras de histamina y su uso en cancer.

Country Status (19)

Country Link
US (2) US20180104287A1 (es)
EP (1) EP3274052A1 (es)
JP (2) JP2018510631A (es)
KR (1) KR102707791B1 (es)
CN (1) CN107709541A (es)
AU (1) AU2016236124B2 (es)
BR (1) BR112017019660A2 (es)
CA (1) CA2980544A1 (es)
CL (1) CL2017002275A1 (es)
CO (1) CO2017009182A2 (es)
GE (1) GEP20207089B (es)
HK (1) HK1251013A1 (es)
IL (1) IL254139B (es)
MX (1) MX2017012359A (es)
PH (1) PH12017501741A1 (es)
RU (1) RU2747390C2 (es)
SG (1) SG11201705479UA (es)
WO (1) WO2016153422A1 (es)
ZA (1) ZA201705121B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201809551TA (en) * 2016-05-09 2018-11-29 Biogaia Ab Selection of bacterial strains useful in allergy treatment
CN108707557B (zh) * 2018-03-23 2021-04-16 景岳生物科技股份有限公司 预防、改善或减缓胰腺癌之益生菌组合物及其应用
BR112020023868A2 (pt) 2018-07-24 2021-04-06 Biogaia Ab Cepa bacteriana de ácido láctico, métodos para a seleção de uma cepa bacteriana de ácido láctico e para produzir melatonina em um indivíduo, produto de combinação, e, uso de uma cepa bacteriana de ácido láctico.
JP7243231B2 (ja) 2019-01-30 2023-03-22 ブラザー工業株式会社 層転写装置
CN111004757B (zh) * 2019-12-31 2021-11-02 深圳市沁帆科技有限公司 一种罗伊氏乳杆菌、微生物菌剂及食物制品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846807B1 (en) * 2003-07-25 2005-01-25 Board Of Regents, The University Of Texas System Colorectal neoplasia prophylaxis
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine

Also Published As

Publication number Publication date
RU2747390C2 (ru) 2021-05-04
US20230241136A1 (en) 2023-08-03
WO2016153422A1 (en) 2016-09-29
BR112017019660A2 (pt) 2018-05-15
EP3274052A1 (en) 2018-01-31
IL254139B (en) 2022-06-01
AU2016236124A1 (en) 2017-09-21
CO2017009182A2 (es) 2017-11-30
RU2017135070A3 (es) 2019-08-06
SG11201705479UA (en) 2017-10-30
CN107709541A (zh) 2018-02-16
AU2016236124B2 (en) 2021-04-15
GEP20207089B (en) 2020-04-10
US20180104287A1 (en) 2018-04-19
PH12017501741A1 (en) 2018-03-19
HK1251013A1 (zh) 2019-01-18
KR102707791B1 (ko) 2024-09-19
JP7140820B2 (ja) 2022-09-21
CL2017002275A1 (es) 2018-03-09
IL254139A0 (en) 2017-10-31
RU2017135070A (ru) 2019-04-08
JP2018510631A (ja) 2018-04-19
KR20170128245A (ko) 2017-11-22
ZA201705121B (en) 2019-10-30
JP2021052795A (ja) 2021-04-08
CA2980544A1 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
PH12017501741A1 (en) Histamine-producing bacterial strains and their use in cancer
MX2017001587A (es) Terapia de combinacion para tratar un paramixovirus.
MX2020011783A (es) Terapia de combinacion que involucra anticuerpos contra claudina 18.2 para tratamiento de cancer.
MX2019003938A (es) Compuestos espirociclicos.
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
MX2021007773A (es) Compuestos inhibidores de egfr.
EA201891340A1 (ru) Лечение рака с использованием 2-дезокси-2-фтор-l-фукозы в комбинации с ингибитором контрольных точек
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
EP3474861A4 (en) COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
PH12017500881B1 (en) Aurora a kinase inhibitor
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
AU2017277478A1 (en) Pharmaceutical combinations for treating cancer
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
MX2017016114A (es) Metodos para tratar o prevenir una proteopatia.
MX2017012553A (es) Compuestos espirociclicos.
MY186475A (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
MX2017014436A (es) Compuestos biciclicos.
MX2018011222A (es) Ambrisentan para uso en el tratamiento de insuficiencia renal aguda.
MX2019005700A (es) Metodos para tratar la osteocondromatosis multiple (mo).
EP3487585A4 (en) OLEOCANTHAL INSULATION AND CANCER TREATMENT
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
NZ711523A (en) Use of sedoheptulose for prevention or treatment of inflammation
EP3485907C0 (en) TREATMENT AND PROPHYLAXIS OF K. PNEUMONIAE INFECTION